ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,642, issued on Nov. 4, was assigned to Corxel Pharmaceuticals Hong Kong Ltd. (Causeway Bay, Hong Kong).
"Metalloenzyme inhibitor compounds" was invented by Steven Sparks (Apex, N.C.), Christopher M. Yates (Raleigh, N.C.), Sammy R. Shaver (Chapel Hill, N.C.) and William J. Hoekstra (Durham, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are compounds having metalloenzyme modulating activity, and methods of treating diseases, disorders, or symptoms thereof mediated by such metalloenzymes. In some embodiments, a provided compound is a compound of Formula I,or a pharmaceutically acceptable salt thereof. In some embodiments, a provided metho...